Man Group PLC Abbott Laboratories Call Options Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $2.32 Million - $2.74 Million	23,200 Added 52.49%	67,400 $7.68 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $604,380 - $674,640	6,000 Added 15.71%	44,200 $4.59 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $32,856 - $36,288	-300 Reduced 0.78%	38,200 $4.34 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $3.47 Million - $4.25 Million	38,500 New	38,500 $4.24 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $21,158 - $24,906	200 New	200 $23,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.